Rapid COVID-19 Antigen Test launched by PerkinElmer Kumar Jeetendra | February 28, 2021 PerkinElmer, Inc. has announced the introduction of the PerkinElmer® COVID-19 Antigen Test for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigen in nasal (NS) or nasopharyngeal (NP) swab specimens. The lateral flow immunoassay test can be used to screen or to assist in diagnoses of COVID-19 in asymptomatic or symptomatic individuals. A positive or negative …
Portable, Reproducible PCR COVID-19 Testing by Gilson Kumar Jeetendra | February 28, 2021 With the ever-increasing demand for COVID-19 testing, laboratories are placed under immense pressure for rapid and reliable analysis. Gilson’s portable Connected smart devices can create a fully traceable and reliable lab environment from wherever you are, bringing confidence to manual pipetting within your COVID workflow and preserving the integrity of your sample. NEW qPCR/PCR Wizard …
FDA clears new robotically helped surgical gadget for transvaginal hysterectomy Kumar Jeetendra | March 1, 2021 The U.S. Food and Drug Administration has approved marketing of the Hominis Surgical System, a brand new robotically-assisted surgical device (RASD) that can help alleviate transvaginal hysterectomy in some patients. The Hominis Surgical System is intended for benign hysterectomy (removal of the uterus for non-cancerous conditions) with salpingo-oophorectomy (elimination of one or both fallopian tubes …
Bio-Plex Pro Human IgG SARS-CoV-2 Serology Assays introduced by Bio-Rad Kumar Jeetendra | March 1, 2021 Bio-Rad Laboratories, Inc., a global pioneer of life science research and clinical diagnostic products, today announced the introduction of the Bio-Plex Pro Human IgG SARS-CoV-2 N/RBD/S1/S2 4-Plex Panel, for research use only (RUO). The qualitative multiplex immunoassay kit quickly and efficiently detects IgG antibodies against four SARS-CoV-2 antigens, allowing vaccine developers to determine therapeutic efficacy …
Quinten spins off 50 data scientists to become a global leader in precision care using artificial intelligence and real-world data science Kumar Jeetendra | March 1, 2021 Paris, France – 1 March, 2021 – – Following the launch of PharmIA, an awarded (1) software to augment and facilitate the prescriptions review by hospital pharmacists, Quinten now launches Quinten Health: a global and integrated analytical services and tools development offer. Quinten Health’s AI-based technologies enable for instance earlier and better diagnosis of rare …
Cipla receives final approval for generic version of GlaxoSmithKline’s IMITREX® (Sumatriptan Nasal Spray, 20 mg) Kumar Jeetendra | March 2, 2021 Mumbai, India, March 02, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ hereinafter referred to as “Cipla”) today announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Sumatriptan Nasal Spray, 20 mg from the United States Food and Drug Administration (U.S. FDA). Cipla’s Sumatriptan Nasal Spray USP, 20 mg …
Covid diseases ascend for first time in quite a while: WHO Kumar Jeetendra | March 2, 2021 The number of new coronavirus infections globally increased a week for the first time in seven weeks, WHO Director-General Tedros Adhanom Ghebreyesus said on Monday. Tedros said the rise was”disappointing but not surprising” and urged countries not to relax measures to fight the spread of this disease. He suggested that countries were hastening to loosen …
J&J CEO Alex Gorsky sees COVID-19 shots in American arms in 1-2 days as transportation begins Kumar Jeetendra | March 2, 2021 Johnson & Johnson’s newly authorized COVID-19 vaccine has begun shipping and its top executive said on Monday that Americans should have the ability to get the single-dose shot over the next 24 to 48 hours, including a third vaccine in america. The drugmaker intends to deliver 4 million vaccine doses this week, 20 million by …
New personalised therapeutics partner joins Repositive Cancer Model network Kumar Jeetendra | March 2, 2021 CAMBRIDGE, UK – (March 2, 2021) – Life Science Newswire – Repositive has announced today that Vivan Therapeutics will be the next company to join its global network of cancer model partners. Based in London, Vivan Therapeutics is an innovative personalised therapeutics company with unique experience in engineering drosophila ‘avatar’ models for cancer research and …
Anthony Fauci presents his own virus model to Smithsonian Kumar Jeetendra | March 3, 2021 Dr. Anthony Fauci, the face of the US government’s pandemic response, has given his personal 3D model of the COVID-19 virus to the Smithsonian’s National Museum of American History. The museum on Tuesday honored Fauci with its Great Americans Medal. “Dr. Fauci has helped save millions of lives and advanced the treatment and our comprehension …
Researchers create shape memory polymer to comprehend the advancement of coronary illness Kumar Jeetendra | March 3, 2021 Cardiovascular disease is still the number one cause of death globally. Unfortunately, the heart cannot regenerate new tissue, because the cardiomyocytes, or heart muscle cells, don’t divide after birth. In their paper, published in APL Bioengineering by AIP Publishing, Syracuse researchers developed a shape memory polymer to grow cardiomyocytes. Raising the substance’s temperature from 30 …
Breast Cancer Cell Line Array Kumar Jeetendra | March 3, 2021 AMSBIO announce a new HER2 control cell line array that was developed and is proven as an effective slide quality control for HER2 expression in breast cancer tissue samples. This new FFPE cell pellet microarray delivers a full dynamic range of HER2, ER and PR expression, validated by the Ventana system, to give immunohistochemical data …
